Barlow Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Barlow Wealth Partners's ABBV Position: Q3 2026 in Review
Barlow Wealth Partners held its AbbVie (ABBV) position steady in Q3 2026 at 4,334 shares worth $1.16M. The position accounts for 0.12% of the portfolio, ranked #53.
Barlow Wealth Partners first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Barlow Wealth Partners held 4,334 shares of AbbVie worth $1.16M as of Q3 2026.
- Barlow Wealth Partners left its AbbVie share count unchanged in Q3 2026.
- AbbVie made up 0.12% of Barlow Wealth Partners's portfolio in Q3 2026, its #53 holding.
- Barlow Wealth Partners first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
- 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Barlow Wealth Partners's 13F filing for Q3 2026, filed 15 Oct 2026.